Metabolic engineering of L-cysteine supply modules for enhanced production of bacitracin in Bacillus licheniformis.
- Author:
Lingfeng LI
1
;
Pei LIU
1
;
Wen LUO
1
;
Qin WANG
1
;
Zhi WANG
2
;
Xiaobin CHEN
3
;
Junhui LI
3
;
Dongbo CAI
1
;
Xin MA
1
;
Shouwen CHEN
1
Author Information
- Publication Type:Journal Article
- Keywords: Bacillus licheniformis; L-cysteinesupply; bacitracin; metabolic engineering
- MeSH: Amino Acids; Bacillus licheniformis/genetics*; Bacitracin; Cysteine; Metabolic Engineering
- From: Chinese Journal of Biotechnology 2021;37(8):2803-2812
- CountryChina
- Language:Chinese
- Abstract: Bacitracin is a broad-spectrum antibiotics mainly produced by Bacillus, and is used as veterinary medicine in the fields of livestock and poultry breeding. Insufficient supply of precursor amino acids might be an important factor that hinders high-level microbial production of bacitracin. We investigated the effect of strengthening L-cysteine supply on bacitracin production by an industrial bacitracin producer, Bacillus licheniformis DW2. Overexpression of cysK encoding L-cysteine synthase led to a 9.17% increase of the bacitracin titer. Moreover, overexpression of cysE encoding L-serine acetyltransferase and cysP encoding thiosulfate/sulfate intracellular transporter increased the bacitracin titers by 7.23% and 8.52%, respectively. Moreover, overexpression of a putative cystine importer TcyP led to a 29.19% increase of intracellular L-cysteine, and bacitracin titer was increased by 7.79%. Subsequently, the strong promoter PbacA was used to replace the promoters of genes cysP, cysE and tcyP in strain DW2::ysK, respectively. The resulted strain CYS4 (DW2::cysK-PbacA-(cysP)-PbacA(cysE)- PbacA(tcyP) produced 910.02 U/mL bacitracin, which was 21.10% higher than that of the original strain DW2 (747.71 U/mL). Together with the experiments in 3 L fermenters, this research demonstrated that enhancing intracellular L-cysteine supply is an effective strategy to increase bacitracin production of B. licheniformis.
